Adjuvant chemotherapy in colon cancer: Can we improve quality of care?

Digestive and Liver Disease

Volumn 45, Issue 8, 2013, Pages 637-638

  Cascinu, Stefano ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT CHEMOTHERAPY; CANCER PROGNOSIS; CANCER SURGERY; CLINICAL PRACTICE; COLON CANCER; COMORBIDITY; FRANCE; HEALTH CARE; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HOSPITAL READMISSION; HUMAN; INCOME; ITALY; LENGTH OF STAY; NETHERLANDS; NOTE; PRACTICE GUIDELINE; PRIORITY JOURNAL; TOTAL QUALITY MANAGEMENT;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; FEMALE; GUIDELINE ADHERENCE; HUMANS; MALE;

EID: 84881546970     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2013.04.011     Document Type: Note

References (9)

1. NIH Consensus Conference: adjuvant therapy for patients with colon and rectal cancer. Journal of the American Medical Association 1990;264:1444-50.
2. Andre T., Boni C., Mounedji-Boudiaf L., et al. Oxaliplatin, fluorouracil and leucovorin as adjuvant treatment for colon cancer. New England Journal of Medicine 2004, 350:2343-2351.
3. Bouvier A.M., Minicozzi P., Grosclaude P., et al. Patterns of adjuvant chemotherapy for stage II and III colon cancer in France and in Italy. Digestive and Liver Disease 2013, 45:687-691.
4. Chagpar R., Xing Y., Chiang Y.J., et al. Adherence to stage specific treatment guidelines for patients with colon cancer. Journal of Clinical Oncology 2012, 30:972-979.
5. Van Steenbergen L.N., Rutten H.J.T., Creemers G.J., et al. Large age and hospital-dependent variation in administration of adjuvant chemotherapy for stage III colon cancer in Southern Netherlands. Annals of Oncology 2010, 21:1273-1278.
6. El Shayeb M., Scarfe A., Yasui Y., et al. Reasons physicians do not recommend and patients refuse adjuvant chemotherapy for stage III colon cancer: a population based chart review. BMC Research Notes 2012, 5:269-277.
7. Winget M., Hossain S., Yasui Y., et al. Characteristics of patients with stage III colon adenocarcinoma who fail to receive guideline-recommended treatment. Cancer 2010, 116:4849-4856.
8. Rayson D., Urquhart R., Cox M., et al. Adherence to clinical practice guidelines for adjuvant chemotherapy for colorectal cancer in a Canadian province: a population-based study. Journal of Oncology Practice 2012, 8:253-260.
9. Parsons H.M., Tuttle T.M., Kuntz K.M., et al. Quality of care along the cancer continuum: does receiving adequate lymph node evaluation for colon cancer lead to comprehensive postsurgical care?. Journal of the American College of Surgeons 2012, 215:400-411.